|
|
|
Volumn 26, Issue 5 SUPPL. 14, 1999, Pages 107-114
|
|
Chronic lymphocytic leukemia
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALEMTUZUMAB;
ALKYLATING AGENT;
BETA 2 MICROGLOBULIN;
CD23 ANTIGEN;
CLADRIBINE;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FLUDARABINE;
MITOXANTRONE;
PREDNISONE;
PROTEIN BCL 2;
PURINE DERIVATIVE;
RITUXIMAB;
VINCRISTINE;
APOPTOSIS;
ARTICLE;
BONE MARROW TRANSPLANTATION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CANCER STAGING;
CHROMOSOME 11;
CHROMOSOME 17;
CHRONIC LYMPHATIC LEUKEMIA;
HUMAN;
IMMUNOPHENOTYPING;
PRIORITY JOURNAL;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD19;
ANTIGENS, CD5;
ANTINEOPLASTIC AGENTS;
BONE MARROW TRANSPLANTATION;
HUMANS;
LEUKEMIA, B-CELL, CHRONIC;
NEOPLASM STAGING;
PROGNOSIS;
RECEPTORS, IGE;
|
|
EID: 0032693874
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (108)
|
|
References (65)
|
